BCAM and urinary bladder carcinoma: On the one hand, BCAM inhibits the adhesion of single OC cells to LN‐511 (presumably by competing for integrin binding), which may have an inhibitory impact on metastasis, consistent with studies of gastrointestinal and bladder carcinoma cells.5, 7